# DOTTER

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dotter

- Industry: Medical Devices & Equipment
- Headquarters: Incheon, South Korea
- Website: www.dotter.com
- Total disclosed funding: $9.8M
- Latest round: Series B (Dec 27, 2024)
- Investors on record: 5

## About

Founded in 2016 and based in Incheon, South Korea, DOTTER Inc. operates as a medical equipment firm that supplies medical devices for patients suffering from heart disease. In October 2023, DOTTER Inc. raised Series B funding from Sneak Peek Investment. As of 2023, the company is led by its CEO, Hyung-il Kim.

DOTTER markets and supplies medical devices for patients suffering from cardiovascular disease. The products and solutions offered by the company include Aurios, which is an optical coherence tomography imaging device; Benetis, which is an OCT imaging catheter; Venavis, which is a double-lumen percutaneous coronary angioplasty (PTCA) catheter; EluNIR Ridaforolimus Eluting Stent System, which is an elastomeric drug-eluting stent; artificial intelligence-based medical software solutions; bioresorbable stents (BRS)-based diagnostic treatment solutions; and many more.

## Funding rounds

- Series B, Dec 27, 2024, $9.8M — Wooshin Venture Capital, Murex Partners, T Investment, Sneak Peek Investment, Clairvoyant Ventures
- Series B, Oct 30, 2023 — Sneak Peek Investment

## Investors

- Sneak Peek Investment (https://capitalatlas.ai/funds/sneak-peek-investment) — Series B
- Wooshin Venture Capital (https://capitalatlas.ai/funds/wooshin-venture-capital) — Series B
- Murex Partners (https://capitalatlas.ai/funds/murex-partners) — Series B
- T Investment (https://capitalatlas.ai/funds/t-investment) — Series B
- Clairvoyant Ventures (https://capitalatlas.ai/funds/clairvoyant-ventures) — Series B